ClinVar Miner

Submissions for variant NM_001110792.2(MECP2):c.1375G>A (p.Ala459Thr)

gnomAD frequency: 0.00009  dbSNP: rs267608626
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel RCV001800447 SCV002047340 benign Rett syndrome 2021-12-13 reviewed by expert panel curation The allele frequency of the p.Ala447Thr (NM_004992.3) variant in MECP2 is 0.02% in East Asian sub population in gnomAD, which is high enough to be classified as likely benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). The p.Ala447Thr variant is observed in at least 2 unaffected individuals (GeneDx internal database) (BS2). In summary, the p.Ala447Thr variant in MECP2 is classified as benign based on the ACMG/AMP criteria (BS1, BS2).
Labcorp Genetics (formerly Invitae), Labcorp RCV001088957 SCV000556730 benign Severe neonatal-onset encephalopathy with microcephaly 2024-01-24 criteria provided, single submitter clinical testing
GeneDx RCV000678237 SCV001815276 likely benign not provided 2021-05-21 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 23810759, 30564305)
Ambry Genetics RCV002381448 SCV002692307 likely benign Inborn genetic diseases 2018-03-06 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
CeGaT Center for Human Genetics Tuebingen RCV000678237 SCV004701566 likely benign not provided 2024-02-01 criteria provided, single submitter clinical testing MECP2: BP4, BS2
Centre for Population Genomics, CPG RCV001800447 SCV004808997 benign Rett syndrome 2024-03-13 criteria provided, single submitter curation This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 3.0 (BA1).
RettBASE RCV000132993 SCV000187979 benign not specified 2013-12-05 no assertion criteria provided curation
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia RCV000678237 SCV000804260 uncertain significance not provided 2015-04-03 no assertion criteria provided clinical testing
PreventionGenetics, part of Exact Sciences RCV004544311 SCV004761074 likely benign MECP2-related disorder 2022-05-26 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.